Operator Protection as Core Design Principle for ADC Bioprocessing
As antibody-drug conjugates gain momentum in biopharma, manufacturers face a crucial challenge: protecting operators from exposure to highly potent compounds while maintaining aseptic processing, containment standards, and efficient commercial-scale production. The post Operator Protection as Core Design Principle for ADC Bioprocessing appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Source
Read the full article at Genengnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.